Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients

被引：11
|
作者：
Ruzzo, A. [1 ]
Canestrari, E. [1 ]
Galluccio, N. [1 ]
Santini, D. [2 ]
Vincenzi, B. [2 ]
Tonini, G. [2 ]
Magnani, M. [1 ]
Graziano, F. [3 ]
机构：
[1] Univ Urbino, Dept Biomol Sci, I-61029 Urbino, Italy
[2] Univ Campus Biomed, Med Oncol Unit, Rome, Italy
[3] Azienda Osped San Salvatore, Dept Oncohematol, Div Oncol, Pesaro, Italy
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷 / 01期
关键词：
CETUXIMAB; BRAF;
D O I：
10.1093/annonc/mdq472
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：234 / U274
页数：2
相关论文
共 50 条
  • [21] Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/− cetuximab
    Janne B Kjersem
    Tone Ikdahl
    Tormod Guren
    Eva Skovlund
    Halfdan Sorbye
    Julian Hamfjord
    Per Pfeiffer
    Bengt Glimelius
    Christian Kersten
    Hiroko Solvang
    Kjell M Tveit
    Elin H Kure
    BMC Cancer, 12
  • [22] Let-7 miRNA-binding site polymorphism in the KRAS 3′UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab
    Kjersem, Janne B.
    Ikdahl, Tone
    Guren, Tormod
    Skovlund, Eva
    Sorbye, Halfdan
    Hamfjord, Julian
    Pfeiffer, Per
    Glimelius, Bengt
    Kersten, Christian
    Solvang, Hiroko
    Tveit, Kjell M.
    Kure, Elin H.
    BMC CANCER, 2012, 12
  • [23] miR128 and LET-7 microRNAs as potential biomarkers for selection of patients with metastatic colorectal cancer candidate to cetuximab/panitumumab therapy
    Landi, L.
    Biagioni, F.
    Ludovini, V.
    Sacconi, A.
    Destro, A.
    Blandino, G.
    Roncalli, M.
    Crin, L.
    Cappuzzo, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Development of KRAS Inhibitors and Their Role for Metastatic Colorectal Cancer
    Deming, Dustin A.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2025, 23 (01):
  • [25] A SNP in a let-7 microRNA Complementary Site in the KRAS 3′ Untranslated Region Increases Non-Small Cell Lung Cancer Risk
    Chin, Lena J.
    Ratner, Elena
    Leng, Shuguang
    Zhai, Rihong
    Nallur, Sunitha
    Babar, Imran
    Muller, Roman-Ulrich
    Straka, Eva
    Su, Li
    Burki, Elizabeth A.
    Crowell, Richard E.
    Patel, Rajeshvari
    Kulkarni, Trupti
    Homer, Robert
    Zelterman, Daniel
    Kidd, Kenneth K.
    Zhu, Yong
    Christiani, David C.
    Belinsky, Steven A.
    Slack, Frank J.
    Weidhaas, Joanne B.
    CANCER RESEARCH, 2008, 68 (20) : 8535 - 8540
  • [26] Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer
    Yun, Jieun
    Frankenberger, Casey A.
    Kuo, Wen-Liang
    Boelens, Mirjam C.
    Eves, Eva M.
    Cheng, Nancy
    Liang, Han
    Li, Wen-Hsiung
    Ishwaran, Hemant
    Minn, Andy J.
    Rosner, Marsha Rich
    EMBO JOURNAL, 2011, 30 (21): : 4500 - 4514
  • [27] The Molecular Basis and Therapeutic Potential of Let-7 MicroRNAs against Colorectal Cancer
    Mizuno, Rei
    Kawada, Kenji
    Sakai, Yoshiharu
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 2018
  • [28] Association of rs712 polymorphism in a let-7 microRNA-binding site of KRAS gene with colorectal cancer in a Mexican population
    Patricia Gallegos-Arreola, Martha
    Moises Zuniga-Gonzalez, Guillermo
    Gomez-Mariscal, Karen
    Alejandra Rosales-Reynoso, Monica
    Figuera, Luis E.
    Maria Puebla-Perez, Ana
    Pineda-Razo, Tomas
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2019, 22 (03) : 324 - 327
  • [29] Role of miRNA Let-7 and Its Major Targets in Prostate Cancer
    Wagner, Siegfried
    Ngezahayo, Anaclet
    Escobar, Hugo Murua
    Nolte, Ingo
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [30] Let-7 microRNA-binding-site polymorphism in the 3′UTR of KRAS and colorectal cancer outcome: a systematic review and meta-analysis
    Langevin, Scott M.
    Christensen, Brock C.
    CANCER MEDICINE, 2014, 3 (05): : 1385 - 1395
12345